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Research (Letter) 
The long pre-clinical phase of Rheumatoid Arthritis (RA), where some factors involved in RA 
pathogenesis circulate peripherally, raises concern of RA transmissibility through blood 
transfusion.1 
We used a large Danish-Swedish population-based research donations and transfusions database 
(SCANDAT2) with health register information on 1.5 million blood donors and 2.1 million 
recipients of their blood to investigate: (1) RA occurrence in recipients of blood from donors who 
later developed RA and (2) clustering of RA among recipients of blood from individual donors, 
regardless of the donor’s RA status.2 3 4 
We used two different approaches to analyze RA transmission. First, we identified all donors who 
developed RA after blood donation. For each of these index donors, we identified up to 10 donors 
matched on age, sex, county, date of first donation, number of donations, and ABO blood group, 
who were free of RA at the date of index donor diagnosis. We then identified all recipients of blood 
from the two donor populations, and followed them from date of transfusion originating in said 
donors until date of RA diagnosis, death, emigration, or end of 2012 (Sweden)/2013 (Denmark), 
whichever came first. 
In the second approach, we investigated if RA clustered among recipients of blood from individual 
donors. Here, we used a modified time-dependent donor riskiness score by simply counting the RA 
occurrences among past recipients of each donor. 
In both approaches, we used Cox regression with age as underlying time scale, with an exposure lag 
of 1 year and strata defined by sex and hospital. All analyses were adjusted for calendar period and 
number of transfusions as restricted cubic splines with 5 equally spaced knots and ABO blood 
group. Persons with RA were identified using contemporary national ICD 7, 8, 9 and 10 
classifications. To reduce misclassification, we defined RA as having two registrations of RA 
within the course of a two-year period. RA diagnoses were further sub-classified as seropositive RA 
or seronegative RA.  
 
Among a total of 938,942 blood donors, 2412 were diagnosed with RA during follow-up. We 
identified 13,369 patients (exposed) who received at least one unit from donors with later RA, and 
139,470 patients (unexposed) who received blood units from the matched donors who were free of 
RA at selection.  
 
Analyses comparing RA occurrence in blood recipients to donors who did versus did not develop 
RA themselves showed that recipient RA risk did not vary by donor RA occurrence (HR = 1.04; 
95% CI 0.80-1.35) (Table 1). Similarly, no association between donor and recipient RA was seen in 
analyses stratified according to RA serotype, donor age or interval between donation and donor RA 











Table 1  Number of cases of rheumatoid arthritis (RA) overall and of seropositive RA and 
seronegative RA, respectively, observed among recipients whose blood donors were (exposed 
recipients) and were not (unexposed recipients) correspondingly diagnosed, with person-years of 




Recipient exposed to: 
Recipient outcome  
Exposed Unexposed 
Events Person-Years Events Person-Years HR (95% CI) 
 Overall RA  
Donor diagnosed with RA 63 82551 610 756275 1.04 (0.80-1.35) 
Shortest latency of donor RA1      
 <10 years 46 59890 610 756275 0.99 (0.56-1.72) 
 10+ years 17 22661 610 756275 1.05 (0.64-1.70) 
Lowest age at donor RA diagnosis      
  < 65 years 51 69827 610 756275 0.80 (0.43-1.51) 
 65+ years  12 12724 610 756275 1.24 (0.70-2.20) 
 Seropositive RA   
Donor with seropositive RA 4 17030 27 186775 1.68 (0.58-4.84) 
 Seronegative RA   
Donor with seronegative RA 9 39829 129 402138 0.72 (0.37-1.43) 
 
1 Interval between donation and donor RA diagnosis. 
 
Analyses of clustering of RA among recipients of blood from individual donors  showed that 
recipient RA risk did not vary by RA occurrence in previous recipients of blood from the same 
donor, neither for all types of RA combined (HR per previous recipient with RA = 0.96; 95% CI 
0.86-1.07) nor for specific RA subtypes. 
The association between RA and blood transfusion history has previously been explored only in a 
small number of investigations, using self-reported transfusion history, which have arrived at 
opposite conclusions.5 6 We restricted our analyses exclusively to transfused patients, and focused 
on the possible link between specific donor factors (e.g., donor RA diagnosis) and recipient RA 
risk. 
In conclusion, we found no evidence that RA or RA risk is transmitted through blood transfusion. 
In light of study strengths, which include low likelihood of confounding and the large study size, 
ensuring meaningful statistical power, we believe it is unlikely that the possibility of RA 
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